In this editor’s desk, Rebekah Jordan shares her views on the achievements within pharma sustainability in 2022, its criticality in pharma investment opportunities, and what’s still to be done.
This website uses cookies to ensure you get the best experience on our website. You can find out more about which cookies we are using in our privacy policy.